Analysis Healthcare & Medical Investment Corporation (3455)
6/5/2024
Analysis of Healthcare & Medical Investment Corporation (3455)
The Healthcare & Medical Investment Corporation (symbol: 3455) has been showing some fluctuations in its stock price recently. Here are some key points from the latest data:1. Price Movement: The stock price has been fluctuating between 128,000 and 132,700. The most recent closing price was 131,500.
2. Technical Indicators:
- RSI Indicator: The Relative Strength Index (RSI) is around 54.54, indicating a neutral sentiment.
- MACD Indicator: The Moving Average Convergence Divergence (MACD) is negative, with the MACD line below the signal line, suggesting a bearish trend.
- Moving Averages: The Simple Moving Average (SMA) is at 131,208, the Exponential Moving Average (EMA) is at 130,723, and the Weighted Moving Average (WMA) is at 130,651.
3. Overall Trend: The stock seems to be in a consolidation phase with mixed signals from technical indicators.
Investors in the Healthcare & Medical Investment Corporation should closely monitor the price levels and key technical indicators to make informed investment decisions.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company had an EPS estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.Financials:
- Cash flow: Operating cash flow TTM is $110,563,000,320 and levered free cash flow TTM is $84,726,874,112.
- Balance sheet: Total cash MRQ is $67,150,000,128, total debt MRQ is $104,590,000,128, current ratio MRQ is 1.037, book value per share MRQ is $4.837, total cash per share MRQ is $4.379, and total debt to equity MRQ is 140.968.
- Profit margin: 26.306%.
- Fiscal year ends: September 30, 2023.
- Income statement: EBITDA is $131,393,000,000, revenue TTM is $381,623,009,280, diluted EPS TTM is $6.43, gross profit TTM is $169,148,000,000, revenue per share TTM is $24.537, net income to common TTM is $100,389,003,264, quarterly revenue growth is -4.3%, and quarterly earnings growth YoY is -2.2%.
- Operating margin: 30.743%.
- Return on assets TTM: 22.073999%.
- Return on equity TTM: 147.25%.
- Most recent quarter: March 31, 2024.
Stock statistics:
- Short ratio: 1.53.
- Float shares: 15,308,320,742.
- Shares short: 99,287,450.
- Average 10-day volume: 46,860,048.
- Average 90-day volume: 57,498,254.
- Shares outstanding: 15,334,099,968.
- Percent held by insiders: 5.22%.
- Percent held by institutions: 57.589%.
- Short percent of shares outstanding: 0.65%.
Valuation metrics:
- PEG ratio: 26.319502.
- Forward PE: 26.319502.
- Trailing PE: 29.59409.
- Enterprise value: $2,950,762,332,160.
- Price to book MRQ: 39.3405.
- Price to sales TTM: 7.646095.
- Enterprise to EBITDA: 22.763.
- Enterprise to revenue: 7.732.
- Market capitalization: $2,917,925,650,432.
Stock price summary:
- Beta: 1.264.
- 50-day moving average: $176.2646.
- 200-day moving average: $181.0429.
- 52-week low: $164.08.
- 52-week high: $199.62.
- 52-week change: 6.853%.
Dividends and splits:
- Payout ratio: 14.93%.
- Dividend date: May 16, 2024.
- Last split date: August 31, 2020.
- Ex-dividend date: May 10, 2024.
- Last split factor: 4-for-1 split.
- Forward annual dividend rate: $1.
- 5-year average dividend yield: 0.73%.
- Forward annual dividend yield: 0.5255%.
- Trailing annual dividend rate: $0.97.
- Trailing annual dividend yield: 0.5097%.
Income statement 💸
Here are the revenue figures for the company over the past four fiscal years:- 2020: $274,515,000,000
- 2021: $365,817,000,000
- 2022: $394,328,000,000
- 2023: $383,285,000,000
From these numbers, we can observe that the company experienced a steady increase in revenue from 2020 to 2022, reaching its peak in 2022. However, there was a slight decrease in revenue in 2023 compared to 2022. This trend indicates a period of growth followed by a slight decline in revenue for the company.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets have fluctuated, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have shown an increasing trend, peaking at $234,386,000,000 in 2018.
4. Total liabilities have also been on the rise, with the highest value in 2018 at $255,355,000,000.
5. Shareholders' equity has generally increased, with the highest value in 2018 at $107,147,000,000.
6. The company has been relying more on non-current liabilities compared to current liabilities.
7. Cash and cash equivalents have varied over the years, with the highest value in 2019 at $48,844,000,000.
8. Investments and advances have shown a consistent increase, reaching $170,799,000,000 in 2018.
9. Machinery, furniture, and equipment have also increased steadily, peaking at $83,140,000,000 in 2023.
10. Accumulated depreciation has been significant, indicating the aging of assets over time.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has been relatively stable over the years, indicating consistent operational performance.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show significant variations, with large amounts being spent on common stock repurchase and debt issuance and payments.
6. Investing activities also vary, with significant amounts being spent on the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company's financial activities show a mix of stability in operating cash flow and fluctuations in investing and financing activities.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average estimated EPS is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average estimated EPS is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This also indicates growth from the EPS of $1.35 in the same quarter last year.
3. Looking at the estimates for the current year ending on September 30, 2024, the average EPS is projected to be $6.10, ranging from a low estimate of $5.95 to a high estimate of $6.41. This reflects an increase from the EPS of $5.67 for the previous year.
4. For the next year ending on September 30, 2025, analysts forecast an average EPS of $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This suggests a slight improvement from the EPS of $6.10 in the previous year.
Overall, the analysts' estimates indicate a positive outlook for the company's earnings per share, with expected growth in both the short term and the long term.
Revenue estimate
Based on analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 25.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 38.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 38.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company over the specified periods, with the highest growth expected in the next fiscal year.
Growth estimates
Based on the consensus estimates provided:- The current year growth rate is 7.6%
- The next quarter growth rate is 5.1%
- The current quarter growth rate is 5.1%
- The next year growth rate is 9.7%
- The average annual growth rate for the next 5 years is 9.7%
- The average annual growth rate for the past 5 years is 20.1%
It can be observed that the company is expected to experience a significant increase in growth compared to the past 5 years, with a particularly strong growth forecast for the next year and the next 5 years. This indicates positive expectations and potential for expansion in the near future.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $275
- Median: $201.43
- Average: $204.58
- Current price: $192.25
- Currency: USD
Based on these forecasts, we can see that the analysts have a range of opinions on the future price of the security, with the low end at $164, the high end at $275, and the average at $204.58. The current price of the security is $192.25, which is below the median and average forecasted prices. Investors should consider these forecasts along with other factors when making decisions about buying or selling the security.
MACD of 3455
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
